文献速递胃肠外科围术期管理与 ERAS

胃癌胃切除术与内镜切除术后2型糖尿病风险的比较:一项全国性队列研究

Comparative Risk of Type 2 Diabetes after Gastrectomy and Endoscopic Resection for Gastric Cancer: A Nationwide Cohort Study.
PubMed 文献 · J Am Coll Surg · 2023-09-19

该回顾性全国性 population-based 队列研究纳入14,646例胃癌患者(胃切除术12,918例,内镜切除1,728例),中位随访8.1年。胃切除术组发生2型糖尿病的风险显著高于内镜切除组(HR 1.37;95%CI 1.18-1.58;p<0.0001),女性患者亚组风险增加更明显(HR 1.72;95%CI 1.22-2.43;交互作用p=0.030)。

要点

  • 胃癌术后存活≥5年、无糖尿病史且未接受辅助化疗者纳入分析。
  • 胃切除术组2型糖尿病发生风险较内镜切除组升高37%(HR 1.37)。
  • 女性患者胃切除术后2型糖尿病风险升高72%(HR 1.72)。

核心结论

  • 在胃癌幸存者中,胃切除术患者发生2型糖尿病的风险较内镜切除术患者增加37%。
  • 亚组分析显示女性患者2型糖尿病风险增加高达72%。
  • 这些结果为根据不同的治疗方式制定胃癌幸存者的筛查和预防策略提供了见解。

研究设计与样本

  • 回顾性全国性 population-based 队列研究。
  • 纳入14,646例胃癌患者,其中胃切除术12,918例,内镜切除术1,728例。
  • 纳入标准:术后存活至少5年、无糖尿病史、未接受辅助化疗。

主要发现

  • 中位随访8.1年,内镜切除组2型糖尿病发病率为7.58/1000人年,胃切除术组为6.98/1000人年。
  • 胃切除术组发生2型糖尿病的风险显著高于内镜切除组(HR 1.37;95%CI 1.18-1.58;p<0.0001)。
  • 亚组分析中,女性患者胃切除术与2型糖尿病风险增加相关(HR 1.72;95%CI 1.22-2.43;交互作用p=0.030)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with gastric cancer (GC) experience 2 characteristic treatment modalities (gastrectomy or endoscopic resection), which may induce heterogeneity in the risk of post-cancer treatment type 2 diabetes (T2D). We investigated differences in the risk for T2D development in survivors of GC according to the 2 treatment methods. STUDY DESIGN: This retrospective nationwide population-based cohort study included 14,646 patients with GC who underwent gastrectomy (n = 12,918) or endoscopic resection (n = 1,728). We enrolled patients who survived for at least 5 years after gastrectomy or endoscopic resection, had no history of diabetes, and had not received adjuvant chemotherapy. T2D risk was evaluated using Cox regression for the gastrectomy group and compared to that of the endoscopic resection group. Because of the competing risks of incident T2D and death, a competing risk regression was performed. RESULTS: After a median follow-up duration of 8.1 years, the incidence rates of T2D in the endoscopic resection group and gastrectomy group were 7.58 and 6.98 per 1,000 person-years, respectively. Patients undergoing gastrectomy showed a significantly higher risk for developing T2D than patients undergoing endoscopic resection (hazard ratio [HR], 1.37; 95% CI 1.18 to 1.58; p < 0.0001). In subgroup analyses, gastrectomy was associated with increased T2D risk in female patients (HR, 1.72; 95% CI 1.22 to 2.43; p = 0.030 for interaction). CONCLUSIONS: Among GC survivors, patients undergoing gastrectomy showed a 37% increased risk of T2D development compared to patients undergoing endoscopic resection. Subgroup analyses showed that T2D risk increased by up to 72% in female patients. These results provide insights for establishing screening and preventive strategies for GC survivors to prevent T2D according to different treatment modalities.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Kwon Y, Kwon JW, Kim J, et al. Comparative Risk of Type 2 Diabetes after Gastrectomy and Endoscopic Resection for Gastric Cancer: A Nationwide Cohort Study. J Am Coll Surg. 2023. PMID: 37725145. doi:10.1097/XCS.0000000000000868

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。